Original articleImpact of Prior Admissions on 30-Day Readmissions in Medicare Heart Failure Inpatients
Section snippets
Definition of Variables Used
We used data from the Mid-Michigan Guidelines Applied in Practice – Heart Failure (GAP-HF) study for our analyses; additional details on this study are available in our other articles.2, 13, 14 In brief, GAP-HF was a collaborative partnership of 15 Michigan community hospitals to assess and improve the quality of inpatient HF care. Each hospital enrolled patients admitted with primary diagnosis of HF during two 6-month periods (from October 1, 2002, to March 31, 2003, and from January 1 to June
Patient Characteristics
The GAP-HF cohort contained index hospitalizations in 1807 unique Medicare inpatients with HF aged 66 years or older. The baseline characteristics (Table 1) were similar to the National Heart Failure Project18 and more recent Medicare HF cohorts.8, 9 In GAP-HF, 1018 patients (56.3%) had not been recently hospitalized, 254 (14.1%) had been admitted once, and 535 (29.6%) had been admitted 2 or more times within the prior 12 months. The median number of patients across the 14 GAP-HF hospitals was
Discussion
We found that in Medicare inpatients with HF, hospitalizations within the prior 12 months strongly increased the odds for 30-day all-cause readmission, improved the discrimination of a widely recommended HF readmission risk model, and clearly separated patients with HF into high-risk and low-risk categories for early rehospitalization.
Conclusion
In Medicare inpatients with HF, all-cause prior admissions within 12 months strongly increased the risk for 30-day all-cause readmission, improved the performance of a widely recommended risk model, and clearly separated patients into high-risk and low-risk categories for early rehospitalization. This easily obtained information could help focus readmission-prevention efforts in older patients with HF.
References (30)
- et al.
The impact of prior heart failure hospitalizations on long-term mortality differs by baseline risk of death
Am J Med
(2012) - et al.
Repeated hospitalizations predict mortality in the community population with heart failure
Am Heart J
(2007) - et al.
Validated, electronic health record deployable prediction models for assessing patient risk of 30-day rehospitalization and mortality in older heart failure patients
JCHF
(2013) - et al.
Predictors of readmission among elderly survivors of admission with heart failure
Am Heart J
(2000) - et al.
Risk stratification after hospitalization for decompensated heart failure
J Card Fail
(2004) - et al.
Prolonged electrocardiogram QRS duration independently predicts long-term mortality in patients hospitalized for heart failure with preserved systolic function
J Card Fail
(2009) - et al.
Recommendation of low-salt diet and short-term outcomes in heart failure with preserved systolic function
Am J Med
(2009) - et al.
Guideline-based standardized care is associated with substantially lower mortality in Medicare patients with acute myocardial infarction: the American College of Cardiology's Guidelines Applied in Practice (GAP) projects in Michigan
J Am Coll Cardiol
(2005) - et al.
Spectrum of heart failure in older patients: results from the National Heart Failure Project
Am Heart J
(2002) - et al.
Predicting the risk of unplanned readmission or death within 30 days of discharge after a heart failure hospitalization
Am Heart J
(2012)
Divergent trends in survival and readmission following a hospitalization for heart failure in the Veterans Affairs health care system 2002 to 2006
J Am Coll Cardiol
Effects of a multidisciplinary, home-based intervention on unplanned readmissions and survival among patients with chronic congestive heart failure: a randomised controlled study
Lancet
An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure
Circ Cardiovasc Qual Outcomes
“Dose-dependent” impact of recurrent cardiac events on mortality in patients with heart failure
Am J Med
Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure
Circulation
Cited by (24)
Insufficient Calorie Intake Worsens Post-Discharge Quality of Life and Increases Readmission Burden in Heart Failure
2020, JACC: Heart FailureCitation Excerpt :Discrimination for all-cause readmission was assessed with and without NRI and caloric intake. For number of days of rehospitalization, which represent overly dispersed count data, negative binomial regression was used, adjusted for NRI category, OPTIMIZE-HF score, randomization to meals versus usual care, and the number of cardiovascular hospitalizations within the previous year (categorized as 0, 1, 2, or more) (23). Among the 57 randomized GOURMET-HF participants with completed FFQ, the median sodium intake was 2,987 mg/day (interquartile range [IQR]: 2,160 to 3,540 mg/day), and the median calorie intake was 1,602 kcal/day (IQR: 1,201 to 2,142 kcal/day); 29 of 57 participants (53%) had insufficient caloric intake (as defined above, <90% of estimated TEE).
Latent topic ensemble learning for hospital readmission cost optimization
2020, European Journal of Operational ResearchCitation Excerpt :However, studies which use LACE on different datasets are often unable to obtain a c-statistic near 0.7 (Philbin & DiSalvo, 1999), and can be as low as 0.55 (Cotter, Bhalla, Wallis, & Biram, 2012). Other models which use similar methods also perform poorly (Hummel, Katrapati, Gillespie, DeFranco, & Koelling, 2014). Little consensus is reached regarding best approaches and many systems are very similar to early works nearly 30 years old.
Economic Impact of Chronic Heart Failure Management in Today's Cost-Conscious Environment
2019, Cardiac Electrophysiology ClinicsCitation Excerpt :As a result, data from 3387 hospitals between 2007 and 2015 have demonstrated significant reductions in readmissions in target and nontarget conditions.46 A study of Medicare patients indicates that prior all-cause admissions within 12 months of an index admission for HF is a strong predictor of 30-day all-cause readmission.47 A 3-phase terrain of readmission risk after index HF hospitalization has been proposed by Chun and colleagues20 with the highest risk of readmissions the first 4 months after discharge and the last months of life.48
Lower Extremity Function Is Independently Associated With Hospitalization Burden in Heart Failure With Preserved Ejection Fraction
2019, Journal of Cardiac FailureCitation Excerpt :The variables comprising the HFPSI include blood urea nitrogen; B-type natriuretic peptide; NYHA class; the presence of diabetes or atrial arrhythmias; and prior all-cause hospitalizations, the strongest predictor of hospital admission in patients with HF. A simple integer score effectively divides patients with HF into 4 risk strata.19 For this analysis, we calculated the HFPSI score using data available at the time of SPPB assessment in the HFpEF clinic (Supplementary Table S3 provides a score calculation).
Implementation of a Multidisciplinary Inpatient Cardiology Service to Improve Heart Failure Outcomes in Guyana
2018, Journal of Cardiac FailureCitation Excerpt :This program was created with the goal of improving cardiovascular outcomes through systematic implementation of evidence-based cardiac interventions with emphasis on sustainability and effective resource utilization. Despite evidence supporting the value of multidisciplinary cardiovascular care services for improving clinical outcomes,7–13 the impact in developing countries has not been well studied. The objective of the present study was to determine the effectiveness of a dedicated inpatient cardiac care program in a resource-poor setting for improving practitioner adherence to guideline-directed HF medical therapy (GDMT) and reducing hospital length of stay, readmission rates, and mortality.
Dietary sodium restriction in heart failure: A recommendation worth its salt?
2016, JACC: Heart Failure
Grant Support: The Mid-Michigan GAP-HF study was conducted in conjunction with the Greater Flint Health Coalition and was funded by unrestricted grants from AstraZeneca Pharmaceuticals, Pfizer, Inc, GlaxoSmithKline, and the Blue Cross Blue Shield of Michigan Foundation. The funding organizations had no role in the design and conduct of this study, the analysis of data, or the preparation of this article. Dr Hummel was supported by a grant from the National Institutes of Health (grant no. NIH/NHLBI K23HL109176). The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.